A rapid discriminative hydrogen–deuterium exchange and LC-HRMS/MS strategy for primary and higher order structural mapping of therapeutic proteins: a case study using filgrastim-Reference-Cited by-同舟云学术

A rapid discriminative hydrogen–deuterium exchange and LC-HRMS/MS strategy for primary and higher order structural mapping of therapeutic proteins: a case study using filgrastim

Published:2023 Issue:12 Volume:15 Page:1527-1535
ISSN:1759-9660
Container-title:Analytical Methods
language:en
Short-container-title:Anal. Methods

Author:

Thakkar Harsh¹^ORCID,Eerla Rameswari¹,Sharma Lokesh¹,Shah Ravi P.¹^ORCID

Affiliation:

1. National Institute of Pharmaceutical Education and Research-Ahmedabad, Opposite Air force Station, Palaj, Gandhinagar 382355, Gujarat, India

Abstract

Amalgamation of hydrogen–deuterium exchange and mass spectrometer for rapid determination of higher order structural differences in therapeutic proteins.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Engineering,General Chemical Engineering,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/AY/D2AY01788A

Reference25 articles.

1. Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of Care

2. The rise of biosimilars: potential benefits and drawbacks in rheumatoid arthritis

4. The Business Research Company , Global Therapeutic Proteins Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends , https://blog.tbrc.info/2021/09/global-therapeutic-proteins-market-report-2021-opportunities-and-strategies-market-forecast-and-trends/ , accessed 12 July 2022

5. Falsification of biotechnology drugs: current dangers and/or future disasters?

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-Engineered Recombinant α-Synuclein: A Gage R&R Validated Protocol;Journal of Proteome Research;2023-11-20